Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00557206 · ClinicalTrials.gov registry record · Phase 2
Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer
A Phase 2 study, sponsored by Minneapolis Veterans Affairs Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00557206: Clinical Trial Phase 2 study, sponsored by Minneapolis Veterans Affairs Medical Center.
NCT00557206 is a Phase 2 study that was terminated before completion, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 35 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00557206, a Phase 2 study, was terminated before completion, sponsored by Minneapolis Veterans Affairs Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
Patient receiving oxaliplatin and docetaxel will have longer progression free survival than those patients receiving standard care.
Interventions
- DRUG Oxaliplatin and Docetaxel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Why NCT00557206 stopped before completion
NCT00557206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Oxaliplatin and Docetaxel is the first listed.
NCT00557206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00557206 about?
NCT00557206 is a clinical study titled "Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer". Patient receiving oxaliplatin and docetaxel will have longer progression free survival than those patients receiving standard care.
What is the current status of trial NCT00557206?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2005-04. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00557206?
The interventions under investigation include: Oxaliplatin and Docetaxel (DRUG).
Who is sponsoring clinical trial NCT00557206?
This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00557206's enrollment target sits among peer trials
35 1524th of 2000 higher than 462 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia